Supplemental material: Allometric Scaling of Testosterone Enanthate Pharmacokinetics to Adolescent Hypogonadal Males (IM and SC Administration)

Published: 20 March 2023| Version 1 | DOI: 10.17632/rzdmvymc8w.1
Contributors:
,
,
,

Description

Supplemental Figure 1: Simulated Individual Predictions for the SC TE Model p3 Supplemental Figure 2: Simulated Individual Predictions for the IM TE Model p4 Supplemental Figure 3: Goodness of Fit for the SC TE Model p5 Supplemental Figure 4: Goodness of Fit for the IM TE Model p6 Supplemental Figure 5: Visual Predictive Check of the SC TE Model p7 Supplemental Figure 6: Visual Predictive Check of the IM TE Model p8 Supplemental Figure 7: Simulated Population (Mean) Predictions for the SC TE Model p9 Supplemental Figure 8: Simulated Population (Mean) Predictions for the IM TE Model p10 Supplemental Table 1: Comparison of Evaluated Compartmental Models and Error Models for the SC TE Model p11 Supplemental Table 2: Comparison of Evaluated Compartmental Models and Error Models for the IM TE Model p12 Supplemental Table 3: Comparison of Final Parameters of SC and IM TE Models p13 Supplemental Table 4: Bootstrap Analysis of the SC TE Model p14 Supplemental Table 5: Bootstrap Analysis of the IM TE Model p15

Files

Institutions

Synteract Inc, Children's Hospital of Philadelphia, Antares Pharma Inc, University of Virginia

Categories

Pharmacokinetics, Testosterone, Allometry

Funders

  • Antares Pharma Inc.

Licence